Relevance of functional neuroimaging in the progression of mild cognitive impairment

Neurological Research

Volumn 26, Issue 5, 2004, Pages 496-501

  Cabranes, José Antonio ^a   De Juan, Ramón ^a   Encinas, Marta ^a   Marcos, Alberto ^a   Gil, Pedro ^a   Fernández, Cristina ^a   De Ugarte, Carmen ^a   Barabash, Ana ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Alzheimer's disease; Mild cognitive impairment; Neuropsychological test; Preclinical marker; SPECT

Indexed keywords

BIOCHEMICAL MARKER;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN MAPPING; CLINICAL ARTICLE; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROPSYCHOLOGICAL TEST; PREDICTION; SCREENING TEST;

BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; CYSTEINE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; NEUROPSYCHOLOGICAL TESTS; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 3042770770     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164104225016155     Document Type: Article

References (38)

1. American Psychiatric Association. Diagnosis and Statistical Manual of Mental Disorders, 4th edn. Washington, DC, 1994
2. World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: World Health Organisation, 1992
3. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-2002
4. Huang C, Wahlund L, Almkvist O, et al. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage 2003; 19: 1137-1144
5. De Carli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurology 2003; 2: 15-21
6. Christensen H, Henderson AS, Jorm AF, et al. ICD-10 mild cognitive disorder: Epidemiological evidence on its validity. Psicol Med 1995; 25: 105-120
7. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349: 1793-1796
8. Crook T, Bartus RT, Ferris SH, et al. Age associated memory impairment: Proposed diagnostic criteria and measures of clinical change: Report of a National Institute of Mental Health Work Group. Dev Neuropsycol 1986; 2: 261-276
9. De Carli C, Miller BL, Swan GE, et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001; 58: 643-647
10. Martinez-Lage P, Martinez-Lage JM. Deterioro cognitivo ligero de causa vascular. Neurología 2002; 17 (Suppl 7): 16-26
11. Arnaiz E, Jelic V, Almkvist O, et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 2001; 12: 851-855
12. Karlawish JH, Clark CM. Diagnostic evaluation of elderly patients with mild memory problems. Ann Intern Med 2003; 138: 411-419
13. Masur DM, Sliwinski M, Lipton RB, et al. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994; 44: 1427-1432
14. Wolf H, Grunwald M, Ecke GM, et al. The prognosis of mild cognitive impairment in the elderly. J Neural Transm Suppl 1998; 54: 31-50
15. Camicioli R, Howieson D, Oken B, et al. Motor slowing precedes cognitive impairment in the oldest old. Neurology 1998; 50: 1496-1498
16. Jack CR Jr, Petersen RC, Xu YC, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55: 484-489
17. Yamaguchi S, Menguro K, Shimada M, et al. Five year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: The Tajiri Project. Neuroradiology 2002; 44: 43-48
18. Kantarci K, Jack CR Jr, Xu YC, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 2000; 55: 210-217
19. 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Ger Soc 1996; 44: 209-211
20. De Leon MJ, Convit A, Wolf OT, et al. Prediction of cognitive decline in normal elderly subjects with 2-((18)F) fluoro-2-deoxi-D-glucose/positron- emission tomography (FDG/PET). Proc Natl Acad Sci USA 2001; 98: 10966-10971
21. Kogure D, Matsuda H, Ohnishi T, et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000; 41: 1155-1562
22. Johson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998; 50: 1563-1572
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
24. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameters for diagnosis and evaluation of dementia (Summary Statement). Neurology 1994; 44: 2203-2206
25. Encinas M, de Juan R, Marcos A, et al. Regional cerebral blood flow assessed with 99mTc-ECD SPECT as a marker of progression of mild cognitive impairment to Alzheimer's disease. Eur J Nucl Med Mol Imag 2003; 30: 1473-1480
26. Busse A, Bischkopf J, Riedel-Heller SG, et al. Mild cognitive impairment: Prevalence and incidence according to different diagnostic criteria: Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry 2003; 182: 449-454
27. Tanaka M, Fukuyama H, Yamaguchi H, et al. Regional cerebral blood flow abnormalities in non demented patients with memory impairment. J Neuroimaging 2002; 12 (2): 112-118
28. Petersen RC, Stevens JC, Ganguli M, et al. Early detection of dementia: Mild cognitive impairment (an evidence based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133-1142
29. Cullum C, Huppert FA, McGee M, et al. Decline across different domains of cognitive functioning in normal ageing: Results of a longitudinal population-based study using CAMCOG. Int Geriatr Psychiatry 2000; 15: 853-862
30. Marquis S, Moore M, Howieson DB, et al. Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 2002; 59: 601-606
31. Palmer K, Wang H, Backman L, et al. Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. Am J Psychiatry 2002; 59: 436-442
32. Visser PJ, Verhey FR, Scheltens P, et al. Diagnostic accuracy of the Preclinical AD scale (PAS) in cognitively mildly impaired subjects. J Neurol 2002; 249: 312-319
33. Arnaiz E, Almkvist O. Neuropychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurol Scand 2003; Suppl. Feb., 179: 34-41
34. De Santi S, de Leon MJ, Rusinek H, et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 2001; 22: 529-539
35. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002; 59: 198-205
36. Chételat G, Desgranges B, de la Sayette V, et al. Mild cognitive impairment: Can FDG-PET predict who will rapidly convert to Alzheimer's disease? Neurology 2003; 60: 1374-1377
37. Chételat G, Desgranges B, de la Sayette V, et al. Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain 2003; 126: 1955-1967
38. Drzezga A, Lautenschlager N, Siebner H, et al. Cerebral metabolic changes accompanyng conversion of mild cognitive impairment into Alzheimer's disease: A PET follow-up study. Eur J Nucl Med Mol Imag 2003; 30: 1104-1113